eClinical Tech News

Medipharm Labs Corp., a pharmaceutical company specializing in precision-based cannabinoids, reported a 14% year-over-year revenue increase to $11.8 million...

MediWound’s Q2 2025 results showcase a company navigating the complex landscape of advanced wound care therapeutics, balancing ongoing commercialization...

Atai Life Sciences’ planned merger with Beckley Psytech, alongside positive Phase 2b trial data for its intranasal mebufotenin benzoate...

Shattuck Labs has submitted an Investigational New Drug (IND) application for SL-325, its lead Death Receptor 3 (DR3) blocking...

Eledon Pharmaceuticals’ recent Q2 2025 update reveals encouraging progress for its lead candidate, tegoprubart, an anti-CD40L antibody, in the...

Inhibikase Therapeutics is advancing IKT-001, a prodrug of imatinib mesylate, toward a Phase 2b clinical trial for the treatment...

Annexon Biosciences’ recent corporate update reveals a company aggressively navigating the complex landscape of complement-mediated drug development, with a...

Camp4 Therapeutics, a clinical-stage biotech focused on RNA-targeting therapeutics, has released its Q2 2025 financial results alongside promising preclinical...

Sanofi’s acquisition of ViceBio for an upfront payment of $1.15 billion, plus potential milestones, signifies a strategic move to...

POP Biotechnologies Secures CEPI Funding to Advance “Plug-and-Play” Vaccine Platform POP Biotechnologies has secured up to $1.5 million in...